Stock 1801 INNOVENT BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Innovent Biologics, Inc.

Equities

1801

KYG4818G1010

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:09 2024-04-25 am EDT 		5-day change 1st Jan Change
38.55 HKD +1.05% Intraday chart for Innovent Biologics, Inc. +14.39% -9.82%
Apr. 17 Innovent Appoints Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer CI
Apr. 02 Hutchmed endometrial cancer treatment application accepted for review AN

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. 1801 Stock
  4. Revisions Innovent Biologics, Inc.